Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portal Vein Tumour Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01690715
What this trial is testing

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisHepatic Portal Vein Tumor Invasion
Hospital Sirio-Libanes 50
Large-scale testing (Phase 3)UnknownNCT03468231
What this trial is testing

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Ended earlyNCT03035006
What this trial is testing

Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Tumor Thrombosis
Taiwan Liposome Company 1
Not applicableStudy completedNCT02848638
What this trial is testing

Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization

Who this might be right for
Carcinoma, Hepatocellular
University of Washington 35
Not applicableUnknownNCT04181931
What this trial is testing

Neo-TACE-HAIC for PVTT-HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Sun Yat-sen University 320
Large-scale testing (Phase 3)Looking for participantsNCT03368651
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 230
Not applicableStudy completedNCT03108248
What this trial is testing

ISP-TACE Versus TACE for HCC With PVTT

Who this might be right for
HCCPortal Vein Tumor Thrombosis
Zhongda Hospital 126
Not applicableStudy completedNCT03477149
What this trial is testing

EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications

Who this might be right for
VaricoceleEndoleakPortal Vein Thrombosis+2 more
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT04771988
What this trial is testing

Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis

Who this might be right for
Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 17
Not applicableStudy completedNCT04966195
What this trial is testing

Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombosisStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06349317
What this trial is testing

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yongyi Zeng 33
Large-scale testing (Phase 3)WithdrawnNCT02149771
What this trial is testing

Combination Treatment for Advanced Liver Cancer

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor Invasion
Shanghai Zhongshan Hospital
Not applicableLooking for participantsNCT05984511
What this trial is testing

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor InvasionTumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University 234
Not applicableStudy completedNCT05040347
What this trial is testing

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein Tumor Thrombosis
The Affiliated Hospital of Qingdao University 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07187284
What this trial is testing

EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 62
Testing effectiveness (Phase 2)UnknownNCT04069949
What this trial is testing

Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus

Who this might be right for
Unresectable Hepatocellular CancerPortal Vein Tumor Thrombus
Sichuan University 39
Not applicableUnknownNCT01033578
What this trial is testing

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Fudan University 260
Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Next Page